Skip to main content
Top
Published in: Journal of Orthopaedic Surgery and Research 1/2015

Open Access 01-12-2015 | Research article

Changes over time in callus formation caused by intermittently administering PTH in rabbit distraction osteogenesis models

Authors: Tetsuya Ohata, Hideto Maruno, Shoichi Ichimura

Published in: Journal of Orthopaedic Surgery and Research | Issue 1/2015

Login to get access

Abstract

Background

Changes over time in the callus during intermittent administration of parathyroid hormone (PTH) were studied in rabbit distraction osteogenesis models.

Method

Models of distraction osteogenesis in Japanese white rabbits were created, and distraction osteogenesis (total length: 10.5 mm) was performed for 2 weeks. Simultaneously with the start of distraction, 30 rabbits received 4 weeks of subcutaneous administration of 30 μg/kg of PTH(1–34), teriparatide, (P-group: n = 15) or saline (N-group: n = 15) every other day. The tibias of five rabbits were dissected at 6, 8, and 10 weeks after surgery to perform bone mineral density (BMD), peripheral quantitative computed tomography (pQCT), and mechanical testing.

Results

The mean BMD had no significant differences over time at 6, 8, and 10 weeks after surgery between the P-group and the N-group. On pQCT, the P-group had significant increases in total bone cross-sectional area of the callus compared to the N-group at 8 and 10 weeks after surgery. On mechanical testing, the P-group’s absorption energy had not changed at 6 weeks after surgery compared to the N-group, but it had significantly increased at 8 weeks. At 10 weeks after surgery, the N-group’s absorption energy rapidly increased, and the difference between the two groups disappeared.

Conclusion

The intermittent administration of PTH(1–34), teriparatide, for 4 weeks every other day from the start of distraction had the potential to shorten the callus maturation period in the rabbit distraction osteogenesis models.
Literature
1.
go back to reference Yasui N, Kawabata H, Kojimoto H. Lengthening of lower limbs in patients with achondroplasia. Clin Orthop. 1997;344:298–306.PubMedCrossRef Yasui N, Kawabata H, Kojimoto H. Lengthening of lower limbs in patients with achondroplasia. Clin Orthop. 1997;344:298–306.PubMedCrossRef
2.
go back to reference Tsuchiya H, Tomita K, Minematsu K. Limb salvage using distraction osteogenesis; a classification of the technique. J Bone Joint Surg. 1997;79-B:403–11.CrossRef Tsuchiya H, Tomita K, Minematsu K. Limb salvage using distraction osteogenesis; a classification of the technique. J Bone Joint Surg. 1997;79-B:403–11.CrossRef
3.
go back to reference Shimazaki A, Inui K, Azuma Y. Low-intensity pulsed ultrasound accelerates bone maturation in distraction osteogenesis in rabbits. J Bone Joint Surg. 2000;82-B:1077–82.CrossRef Shimazaki A, Inui K, Azuma Y. Low-intensity pulsed ultrasound accelerates bone maturation in distraction osteogenesis in rabbits. J Bone Joint Surg. 2000;82-B:1077–82.CrossRef
4.
go back to reference Shizuto M, Hiroyuki S, Kazuto N. The effect of low energy extracorporeal shock wave on the callus formation during bone lengthening. J Jpn Assoc External Fixation Limb Lengthening. 2003;14:119–22. Shizuto M, Hiroyuki S, Kazuto N. The effect of low energy extracorporeal shock wave on the callus formation during bone lengthening. J Jpn Assoc External Fixation Limb Lengthening. 2003;14:119–22.
5.
go back to reference Kouei K, Yuichi T, Motoo H. The effect of alternating current electrical stimulation to the lengthened callus in a experimental callotasis model. Orthop Surg Traumatol. 2002;45:315–9. Kouei K, Yuichi T, Motoo H. The effect of alternating current electrical stimulation to the lengthened callus in a experimental callotasis model. Orthop Surg Traumatol. 2002;45:315–9.
6.
go back to reference Kassis B, Glorin C, Tabib W. Callus response to micromovement after elongation in the rabbit. J Pediatr Orthop. 1996;16:480–3.PubMedCrossRef Kassis B, Glorin C, Tabib W. Callus response to micromovement after elongation in the rabbit. J Pediatr Orthop. 1996;16:480–3.PubMedCrossRef
7.
go back to reference Okazaki H, Kurokawa T, Nakamura K. Stimulation of bone formation by recombinant fibroblast growth factor-2 in callotasis bone lengthening of rabbits. Calcif Tissue Int. 1999;64:542–6.PubMedCrossRef Okazaki H, Kurokawa T, Nakamura K. Stimulation of bone formation by recombinant fibroblast growth factor-2 in callotasis bone lengthening of rabbits. Calcif Tissue Int. 1999;64:542–6.PubMedCrossRef
8.
go back to reference Schumacher B, Albrechtsen J, Keller J. Periosteal insulin–like rowth factor I and bone formation. Acta Orthop Scand. 1996;67:237–41.PubMedCrossRef Schumacher B, Albrechtsen J, Keller J. Periosteal insulin–like rowth factor I and bone formation. Acta Orthop Scand. 1996;67:237–41.PubMedCrossRef
9.
go back to reference Tsubota S, Tsuchiya H, Shinokawa Y. Transplantation of osteoblast-like cells to the distracted callus in rabbits. J Bone Joint Surg. 1999;81-B:125–9.CrossRef Tsubota S, Tsuchiya H, Shinokawa Y. Transplantation of osteoblast-like cells to the distracted callus in rabbits. J Bone Joint Surg. 1999;81-B:125–9.CrossRef
10.
go back to reference Little DG, Cornell MS, Hile MS. Effect of pamidronate on distraction osteogenesis and fixator-related osteoporosis. Injury. 2001;32:14–20.CrossRef Little DG, Cornell MS, Hile MS. Effect of pamidronate on distraction osteogenesis and fixator-related osteoporosis. Injury. 2001;32:14–20.CrossRef
11.
go back to reference Mashiba T, Turner CH, Hirano T. The effects of suppressed bone turnover by bisphoshonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res. 2000;15:613–20.PubMedCrossRef Mashiba T, Turner CH, Hirano T. The effects of suppressed bone turnover by bisphoshonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res. 2000;15:613–20.PubMedCrossRef
12.
go back to reference Mashiba T, Turner CH, Hirano T. The effects of suppressed bone turnover by bisphoshonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites of beagles. Bone. 2001;28:524–31.PubMedCrossRef Mashiba T, Turner CH, Hirano T. The effects of suppressed bone turnover by bisphoshonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites of beagles. Bone. 2001;28:524–31.PubMedCrossRef
13.
go back to reference Neer RM, Arnaud CD, Zanchetta JR. Effect of parathyroid hormone (1–34) on fracture and bone mineral density in postmenopausal women with osteoporosis. N Eng J Med. 2001;344:1434–41.CrossRef Neer RM, Arnaud CD, Zanchetta JR. Effect of parathyroid hormone (1–34) on fracture and bone mineral density in postmenopausal women with osteoporosis. N Eng J Med. 2001;344:1434–41.CrossRef
14.
go back to reference Takami M, Kiyoshi N, Hiroshi N. Effect and safety of intermittent weekly administration of human parathyroid hormone 1–34 in patients with primary osteoporosis evaluated by histomorphometry and microstructural analysis of iliac trabecular bone before and after 1 year of treatment. J Bone Miner Metab. 2004;22:569–76.CrossRef Takami M, Kiyoshi N, Hiroshi N. Effect and safety of intermittent weekly administration of human parathyroid hormone 1–34 in patients with primary osteoporosis evaluated by histomorphometry and microstructural analysis of iliac trabecular bone before and after 1 year of treatment. J Bone Miner Metab. 2004;22:569–76.CrossRef
15.
go back to reference Maruno H. Effects of intermittent administration of parathyroid hormone on distraction osteogenesis in rabbits. J Kyorin Med Soc. 2011;42:29–38. Maruno H. Effects of intermittent administration of parathyroid hormone on distraction osteogenesis in rabbits. J Kyorin Med Soc. 2011;42:29–38.
16.
go back to reference Aleksyniene R, Thomsen JS, Eckardt H. Three-dimensional microstructural properties of regenerated mineralizing tissue after PTH (1–34) treatment in a rabbit tibial lengthening model. J Musculoskelet Neuronal Interact. 2009;9:268–77.PubMed Aleksyniene R, Thomsen JS, Eckardt H. Three-dimensional microstructural properties of regenerated mineralizing tissue after PTH (1–34) treatment in a rabbit tibial lengthening model. J Musculoskelet Neuronal Interact. 2009;9:268–77.PubMed
17.
go back to reference Hock JM, Gera I. Effect of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. J Bone Miner Res. 1992;7:65–72.PubMedCrossRef Hock JM, Gera I. Effect of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. J Bone Miner Res. 1992;7:65–72.PubMedCrossRef
18.
go back to reference Jiang Y, Zhao J, Mitlak B. Recombinant human parathyroid hormone (1–34) [teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res. 2003;18:1932–41.PubMedCrossRef Jiang Y, Zhao J, Mitlak B. Recombinant human parathyroid hormone (1–34) [teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res. 2003;18:1932–41.PubMedCrossRef
19.
go back to reference Dempster DW, Cosman F, Kurland ES. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res. 2001;16:1846–53.PubMedCrossRef Dempster DW, Cosman F, Kurland ES. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res. 2001;16:1846–53.PubMedCrossRef
20.
go back to reference Hodsman AB, Kisiel M, Adachi JD. Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH (1–34) therapy in women with severe osteoporosis. Bone. 2000;27:311–8.PubMedCrossRef Hodsman AB, Kisiel M, Adachi JD. Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH (1–34) therapy in women with severe osteoporosis. Bone. 2000;27:311–8.PubMedCrossRef
21.
go back to reference Manabe T, Mori S, Mashiba T. Human parathyroid hormone (1–34) accelerates natural fracture healing process in the femoral osteotomy model of cynomolgus monkeys. Bone. 2007;40:1475–82.PubMedCrossRef Manabe T, Mori S, Mashiba T. Human parathyroid hormone (1–34) accelerates natural fracture healing process in the femoral osteotomy model of cynomolgus monkeys. Bone. 2007;40:1475–82.PubMedCrossRef
22.
go back to reference Hansen S, Hauge EM, Beck Jensen JE. Differing effects of p TH1–34, p TH1–84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: an 18-month open-labeled observational study using HR-pQCT. J Bone Miner Res. 2013;28:736–45.PubMedCrossRef Hansen S, Hauge EM, Beck Jensen JE. Differing effects of p TH1–34, p TH1–84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: an 18-month open-labeled observational study using HR-pQCT. J Bone Miner Res. 2013;28:736–45.PubMedCrossRef
23.
go back to reference Silverman S, Miller P, Sebba A. The direct assessment of nonvertebral fractures in community experience (DANCE) study: 2-year nonvertebral fragility fracture results. Osteoporos Int. 2013;24:2309–17.PubMedCentralPubMedCrossRef Silverman S, Miller P, Sebba A. The direct assessment of nonvertebral fractures in community experience (DANCE) study: 2-year nonvertebral fragility fracture results. Osteoporos Int. 2013;24:2309–17.PubMedCentralPubMedCrossRef
24.
go back to reference Alkhiary YM, Gerstenfeld LC, Krall E. Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1–34). J Bone Joint Surg. 2005;87:731–41.PubMedCrossRef Alkhiary YM, Gerstenfeld LC, Krall E. Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1–34). J Bone Joint Surg. 2005;87:731–41.PubMedCrossRef
25.
go back to reference Holzer G, Majeska RJ, Lundy MW. Parathyroid hormone enhances fracture healing. Clin Orthop Relat Res. 1999;366:258–63.PubMedCrossRef Holzer G, Majeska RJ, Lundy MW. Parathyroid hormone enhances fracture healing. Clin Orthop Relat Res. 1999;366:258–63.PubMedCrossRef
26.
go back to reference Toru H, Burr DB, Turner CH. Anabolic effects of human biosynthetic parathyroid hormone fragment (1–34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits. J Bone Miner Res. 1999;14:536–45.CrossRef Toru H, Burr DB, Turner CH. Anabolic effects of human biosynthetic parathyroid hormone fragment (1–34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits. J Bone Miner Res. 1999;14:536–45.CrossRef
27.
go back to reference Andreassen TT, Ejersted C, Oxlund H. Intermittent parathyroid hormone (1–34) treatment increases callus formation and mechanical strength of healing rat fractures. J Bone Miner Res. 1999;14:960–8.PubMedCrossRef Andreassen TT, Ejersted C, Oxlund H. Intermittent parathyroid hormone (1–34) treatment increases callus formation and mechanical strength of healing rat fractures. J Bone Miner Res. 1999;14:960–8.PubMedCrossRef
28.
go back to reference Andreassen TT, Flederius C, Ejersted C. Increases in callus formation and mechanical strength of fracture healing in old rats treated with parathyroid hormone. Acta Orthop Scand. 2001;72:304–7.PubMedCrossRef Andreassen TT, Flederius C, Ejersted C. Increases in callus formation and mechanical strength of fracture healing in old rats treated with parathyroid hormone. Acta Orthop Scand. 2001;72:304–7.PubMedCrossRef
29.
go back to reference Nakajima A, Shimoji N, Shiomi K. Mechanism for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1–34). J Bone Miner Res. 2002;17:2038–47.PubMedCrossRef Nakajima A, Shimoji N, Shiomi K. Mechanism for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1–34). J Bone Miner Res. 2002;17:2038–47.PubMedCrossRef
30.
go back to reference Seebach C, Skripitz R, Andreassen TT. Intermittent parathyroid hormone (1–34) enhances mechanical strength and density of new bone after distraction osteogenesis in rats. J Orthop Res. 2004;22:472–8.PubMedCrossRef Seebach C, Skripitz R, Andreassen TT. Intermittent parathyroid hormone (1–34) enhances mechanical strength and density of new bone after distraction osteogenesis in rats. J Orthop Res. 2004;22:472–8.PubMedCrossRef
31.
go back to reference Aleksyniene R, Eckardt H, Bundgaard K. Effects of parathyroid hormone on newly regenerated bone during distraction osteogenesis in a rabbit tibial lengthening model. A pilot study. Medicina. 2006;42:38–48.PubMed Aleksyniene R, Eckardt H, Bundgaard K. Effects of parathyroid hormone on newly regenerated bone during distraction osteogenesis in a rabbit tibial lengthening model. A pilot study. Medicina. 2006;42:38–48.PubMed
32.
go back to reference Aleksyniene R, Thomsen JS, Eckardt H. Parathyroid hormone PTH (1–34) increases the volume, mineral content, and mechanical properties of regenerated mineralizing tissue after distraction osteogenesis in rabbits. Acta Orthop. 2009;80:716–23.PubMedCentralPubMedCrossRef Aleksyniene R, Thomsen JS, Eckardt H. Parathyroid hormone PTH (1–34) increases the volume, mineral content, and mechanical properties of regenerated mineralizing tissue after distraction osteogenesis in rabbits. Acta Orthop. 2009;80:716–23.PubMedCentralPubMedCrossRef
Metadata
Title
Changes over time in callus formation caused by intermittently administering PTH in rabbit distraction osteogenesis models
Authors
Tetsuya Ohata
Hideto Maruno
Shoichi Ichimura
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Journal of Orthopaedic Surgery and Research / Issue 1/2015
Electronic ISSN: 1749-799X
DOI
https://doi.org/10.1186/s13018-015-0228-2

Other articles of this Issue 1/2015

Journal of Orthopaedic Surgery and Research 1/2015 Go to the issue